Deutsche Bank’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.51M | Sell |
71,869
-527,604
| -88% | -$11.9M | ﹤0.01% | 1937 |
|
|
2025
Q4 | $13.8M | Sell |
599,473
-946,628
| -61% | -$31.1M | ﹤0.01% | 987 |
|
|
2025
Q3 | $46.5M | Sell |
1,546,101
-119,751
| -7% | -$3.59M | 0.02% | 640 |
|
|
2025
Q2 | $60.6M | Sell |
1,665,852
-35,641
| -2% | -$1.28M | 0.02% | 565 |
|
|
2025
Q1 | $61.6M | Buy |
1,701,493
+8,385
| +0.5% | +$349K | 0.02% | 563 |
|
|
2024
Q4 | $71.2M | Buy |
1,693,108
+4,137
| +0.2% | +$205K | 0.03% | 552 |
|
|
2024
Q3 | $93.8M | Sell |
1,688,971
-93,369
| -5% | -$4.76M | 0.04% | 421 |
|
|
2024
Q2 | $73.3M | Buy |
1,782,340
+575,115
| +48% | +$24.6M | 0.03% | 447 |
|
|
2024
Q1 | $56.4M | Buy |
1,207,225
+34,359
| +3% | +$1.62M | 0.03% | 525 |
|
|
2023
Q4 | $56.1M | Buy |
1,172,866
+225,134
| +24% | +$8.73M | 0.03% | 489 |
|
|
2023
Q3 | $33.8M | Buy |
947,732
+60,001
| +7% | +$2.38M | 0.02% | 566 |
|
|
2023
Q2 | $41M | Sell |
887,731
-490
| -0.1% | -$22.7K | 0.02% | 560 |
|
|
2023
Q1 | $35.6M | Buy |
888,221
+26,542
| +3% | +$1.14M | 0.02% | 607 |
|
|
2022
Q4 | $39.9M | Buy |
861,679
+32,012
| +4% | +$1.26M | 0.02% | 576 |
|
|
2022
Q3 | $34.4M | Buy |
829,667
+341,959
| +70% | +$17.6M | 0.02% | 612 |
|
|
2022
Q2 | $29.1M | Buy |
487,708
+122,180
| +33% | +$7.52M | 0.02% | 684 |
|
|
2022
Q1 | $26.5M | Sell |
365,528
-89,805
| -20% | -$6.25M | 0.01% | 761 |
|
|
2021
Q4 | $38.3M | Buy |
455,333
+99,547
| +28% | +$8.1M | 0.02% | 664 |
|
|
2021
Q3 | $32.1M | Sell |
355,786
-23,095
| -6% | -$2.09M | 0.02% | 737 |
|
|
2021
Q2 | $36.1M | Sell |
378,881
-47,965
| -11% | -$5M | 0.02% | 707 |
|
|
2021
Q1 | $48.6M | Sell |
426,846
-33,358
| -7% | -$4.54M | 0.03% | 597 |
|
|
2020
Q4 | $63.7M | Buy |
460,204
+28,343
| +7% | +$3.36M | 0.04% | 426 |
|
|
2020
Q3 | $35.5M | Sell |
431,861
-49,607
| -10% | -$4.11M | 0.02% | 543 |
|
|
2020
Q2 | $37.7M | Buy |
481,468
+6,610
| +1% | +$438K | 0.03% | 517 |
|
|
2020
Q1 | $21.1M | Buy |
474,858
+36,989
| +8% | +$1.92M | 0.02% | 629 |
|
|
2019
Q4 | $18.7M | Sell |
437,869
-24,508
| -5% | -$1.01M | 0.01% | 812 |
|
|
2019
Q3 | $19.8M | Sell |
462,377
-87,618
| -16% | -$4.76M | 0.01% | 783 |
|
|
2019
Q2 | $34.9M | Buy |
549,995
+98,699
| +22% | +$6.28M | 0.02% | 722 |
|
|
2019
Q1 | $31.3M | Buy |
451,296
+264,422
| +141% | +$15.1M | 0.02% | 781 |
|
|
2018
Q4 | $8.12M | Sell |
186,874
-110,679
| -37% | -$6.05M | 0.01% | 1442 |
|
|
2018
Q3 | $22.7M | Sell |
297,553
-29,467
| -9% | -$2.4M | 0.01% | 1059 |
|
|
2018
Q2 | $25.1M | Sell |
327,020
-37,149
| -10% | -$2.4M | 0.01% | 1043 |
|
|
2018
Q1 | $18.6M | Buy |
364,169
+180,492
| +98% | +$9.09M | 0.01% | 1166 |
|
|
2017
Q4 | $8.52M | Sell |
183,677
-178,443
| -49% | -$8.75M | 0.01% | 1619 |
|
|
2017
Q3 | $19.3M | Buy |
362,120
+154,793
| +75% | +$9.17M | 0.01% | 1058 |
|
|
2017
Q2 | $12.9M | Buy |
207,327
+54,237
| +35% | +$3.27M | 0.01% | 1218 |
|
|
2017
Q1 | $10.4M | Sell |
153,090
-22,193
| -13% | -$1.69M | 0.01% | 1241 |
|
|
2016
Q4 | $12.3M | Sell |
175,283
-38,982
| -18% | -$2.77M | 0.01% | 1134 |
|
|
2016
Q3 | $15.2M | Buy |
214,265
+55,799
| +35% | +$3.56M | 0.01% | 1051 |
|
|
2016
Q2 | $7.75M | Sell |
158,466
-57,811
| -27% | -$3.74M | 0.01% | 1464 |
|
|
2016
Q1 | $13.7M | Buy |
216,277
+50,751
| +31% | +$3.32M | 0.01% | 1088 |
|
|
2015
Q4 | $18.6M | Buy |
165,526
+59,173
| +56% | +$5.92M | 0.01% | 951 |
|
|
2015
Q3 | $10.2M | Buy |
106,353
+43,835
| +70% | +$5.02M | 0.01% | 1270 |
|
|
2015
Q2 | $6.4M | Buy |
62,518
+11,515
| +23% | +$894K | ﹤0.01% | 1636 |
|
|
2015
Q1 | $3.17M | Buy |
51,003
+50,968
| +145,623% | +$2.83M | ﹤0.01% | 2122 |
|
|
2014
Q4 | $1K | Sell |
35
-2,650
| -99% | -$121K | ﹤0.01% | 6085 |
|
|
2014
Q3 | $150K | Buy |
2,685
+1,145
| +74% | +$57.6K | ﹤0.01% | 4253 |
|
|
2014
Q2 | $69K | Sell |
1,540
-20,300
| -93% | -$836K | ﹤0.01% | 4773 |
|
|
2014
Q1 | $1.07M | Buy |
+21,840
| New | +$1.12M | ﹤0.01% | 2819 |
|
Other funds holding RARE
VPM
VCM
RI
SI
BG
Deutsche Bank's RARE Position: Q1 2026 in Review
Deutsche Bank reduced its Ultragenyx Pharmaceutical (RARE) stake by 88% in Q1 2026, selling an estimated $11.9M and leaving 71,869 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1937.
Deutsche Bank first reported a position in RARE in Q1 2014 and has held it in 49 quarters since. The position peaked at $93.8M in Q3 2024. 295 funds tracked by Wall St. Rank hold RARE as of Q1 2026.
- Deutsche Bank held 71,869 shares of Ultragenyx Pharmaceutical worth $1.51M as of Q1 2026.
- Deutsche Bank sold 527,604 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $11.9M.
- Ultragenyx Pharmaceutical made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1937 holding.
- Deutsche Bank first reported a position in Ultragenyx Pharmaceutical in Q1 2014 and has held it in 49 quarters since.
- Deutsche Bank's Ultragenyx Pharmaceutical position peaked at $93.8M in Q3 2024.
- 295 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.